DCSTRUCT ID 04021 (Collection)

Project:

idg drugcentral drugs

Project (Entity type)

Dcc Asset:

IDG C2M2 2024-01-09 datapackage validated.zip

Processed File (Entity type)

Dcc:

IDG

DCC (Entity type)

Compound:

3-[12-[1-[1-[13,17-Bis(2-carboxyethyl)-7-(1-hydroxyethyl)-3,8,12,18-tetramethyl-21,22-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(2-carboxyethyl)-7-(1-hydroxyethyl)-3,8,13,17-tetramethyl-21,22-dihydroporphyrin-2-yl]propanoic acid

Compound (Entity type)

Collection:

drugcentral drug 04021.json

File (Entity type)

Persistent Id:https://druggablegenome.net/cfde_idg_drugcentral_drugs..collection_DCSTRUCT_ID_04021

Description:DrugPage Collection: (DrugCentralID:04021; PubChem_CID:135577896, FILE=drugcentral_drug_04021.json)

Creation Time:2023-06-07 00:00:00.000000

Abbreviation:drugcentral_drug_04021_collection

Results found

Linked to

	Label	Description
	drugcentral drug 04021.json File (Entity type)	A 3.64 KB file from IDG as part of the idg drugcentral drugs project
	3-[12-[1-[1-[13,17-Bis(2-carboxyethyl)-7-(1-hydroxyethyl)-3,8,12,18-tetramethyl-21,22-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(2-carboxyethyl)-7-(1-hydroxyethyl)-3,8,13,17-tetramethyl-21,22-dihydroporphyrin-2-yl]propanoic acid Compound (Entity type)	A Compound

drugcentral drug 04021.json

File (Entity type)

A 3.64 KB file from IDG as part of the idg drugcentral drugs project

Compound (Entity type)

A Compound

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.